3 reports

HENCE, PEG-FILGRASTIM HAS A DISTINCT ADVANTAGE IN TERMS OF PATIENT SAFETY AGAINST FILGRASTIM.

  • Biochemical
  • United States
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.

Suzhou is a large city with urban population of one million.

  • Biochemical
  • China
  • Beijing Ruide Hetong Medicine Co., Ltd.
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Henan Sino-American Biotechnology Co., Ltd.

s Neupogen (filgrastim), which was originally licensed in 1991.

  • Biochemical
  • Affymetrix, Inc.
  • Life Technologies Corporation
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.